EUVIMEDEUVIMED entdecken
Crossref

Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy

Farkhanda Noureen, Abdur Rehman, Asif Hanif

The International Journal of Frontier Sciences · 2017

DOI: 10.37978/tijfs.v1i2.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Frontier Sciences, 2017. Verfasst von Farkhanda Noureen und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis is a global pandemic which affects millions of people every year. The treatment of tuberculosis consists of simultaneous use of several drugs for a prolonged period of time, therefore anti-tuberculosis treatment induced toxicity is a real problem. It is the most common side effect leading to interruption of therapy. Wide variations have been found in the reported incidence of hepatotoxicity during short-course chemotherapy. This study was conducted to determine the frequency of ATT induced hepatotoxicity in pulmonary TB patients.Methodology: This descriptive, cross-sectional study was conducted at Gulab Devi Chest Hospital Lahore from November 2015 to January 2016. Total 137 pulmonary TB patients were included in this study according to inclusion and exclusion criteria. Data of patients was collected by Questionnaire. Blood samples were taken and LFTs were done. Data was analyzed by using SPSS version 16.

Results

Data of 137 patients was taken in the study. Out of which 60 (43.8%) were male and 77 (56.2%) were female. The mean age was 40.59±16.57. 45 (32.8%) patients out of 137, develop hepatotoxicity while 92 (67.2%) shows normal patterns of liver function. 22 (16.1%) patients out of 137 showed elevation of serum bilirubin levels.

Conclusion

ATT induced hepatotoxicity is a frequent complication in Pulmonary Tuberculosis patients. So, all patients put on ATT must be followed up for at least the initial month. The patients and the treating physicians must be well-educated about the adverse effects of the ATT, its early recognition and management.

Zitieren

APA

Noureen, F., Rehman, A., & Hanif, A. (2017). Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy. The International Journal of Frontier Sciences. https://doi.org/10.37978/tijfs.v1i2.18

Vancouver

Noureen F, Rehman A, Hanif A. Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy. The International Journal of Frontier Sciences. 2017. doi:10.37978/tijfs.v1i2.18

BibTeX
@article{Noureen2017,
  author = {Noureen, Farkhanda and Rehman, Abdur and Hanif, Asif},
  title = {Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy},
  journal = {The International Journal of Frontier Sciences},
  year = {2017},
  doi = {10.37978/tijfs.v1i2.18}
}
Kostenlos starten →